Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-98-000075
Filing Date
1998-03-06
Accepted
1998-03-06 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/AMENDMENT NO. 1 SC 13G/A 8280
  Complete submission text file 0000947871-98-000075.txt   10044
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

EIN.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45417 | Film No.: 98559121
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND V8
Business Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND 2128302413
NOVARTIS INC (Filed by) CIK: 0001030617 (see all company filings)